You are here

Article info

Article menu

Download PDFPDF

Editorial
Perspectives on COVID-19 and cancer immunotherapy: a review series

Authors

  • Jason D Goldman Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA, USA Providence St. Joseph Health, Renton, WA, USA Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA Vaccine and Infectious Disease Division, Fred Hutch, Seattle, WA, USA PubMed articlesGoogle scholar articles
  • Paolo Antonio Ascierto Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Paolo Antonio Ascierto; paolo.ascierto{at}gmail.com

Citation

Goldman JD, Ascierto PA
Perspectives on COVID-19 and cancer immunotherapy: a review series
Journal for ImmunoTherapy of Cancer 2021;9:e002489. doi: 10.1136/jitc-2021-002489

Publication history

  • Accepted February 1, 2021
  • First published March 9, 2021.
Online issue publication 
February 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.